Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Stallergenes Greer plc
DescriptionSublingual tablet of Japanese cedar allergen extracts
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase II
Standard IndicationAllergy
Indication DetailsTreat Japanese cedar allergy
Regulatory Designation
PartnerShionogi & Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today